Milestone is a promising startup in the biotechnology and health care industries, offering advanced services for cell and gene therapy. Established in 2014, the company has recently received a significant CNY100.00M Series A investment on 22 August 2023 from a consortium of notable investors including Addor Capital, Shanghai Titan Technology, Hillhouse Ventures, Tongyu Fund, and Zhongke Haichuang. This strategic investment is a testament to the potential and innovative approach of Milestone in revolutionizing the biotechnology and health care sectors.
General Information
BounceWatch is an independent company data service, not affiliated with Milestone. To contact Milestone, visit miles-bio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Milestone compare?
A PDF of Milestone and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Milestone soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Milestone
Funding Rounds & Investors (1)
View AllMilestone Alternatives & Competitors
View All AlternativesCell and Gene Therapy Experts
Cell and Gene Therapy Manufacturing
Pragmatic digital solutions for Cell and Gene Therapy Manufacturing
FAQ About Milestone
Source: BounceWatch company record for Milestone, https://bouncewatch.com/company/milestone-2, updated 29 October 2024. When citing, please name BounceWatch and link this page.